Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/07 → 31/12/07 |
Funding
- Pfizer (Australia) (trading as Pfizer Australia Pty Limited): A$50,000.00
Role of blood collagen turnover markers in reverse remodelling following cardiac resynchronisation therapy in advanced heart failure
- Elsik, Maros (Primary Chief Investigator (PCI))
- Krum, Henry (Chief Investigator (CI))
- Schneider, Hans-Gerhard (Chief Investigator (CI))
Project: Research